173 related articles for article (PubMed ID: 353210)
21. Effects of combined immunotherapy with levamisole and Bacillus Calmette-Guérin on immunocompetence of patients with squamous cell carcinoma of the cervix, head and neck, and lung undergoing radiation therapy.
Olkowski ZL; McLaren JR; Skeen MJ
Cancer Treat Rep; 1978 Nov; 62(11):1651-61. PubMed ID: 310339
[TBL] [Abstract][Full Text] [Related]
22. Spontaneous rosette formation and rosette inhibition assays in patients with squamous cell carcinoma of the head and neck.
Deegan MJ; Coulthard SW
Cancer; 1977 May; 39(5):2137-41. PubMed ID: 322852
[TBL] [Abstract][Full Text] [Related]
23. The usefulness of pretreatment DNCB in 85 patients with squamous cell carcinoma of the upper aerodigestive tract.
Gilbert HA; Kagan AR; Miles J; Flores L; Nussbaum H; Rao AR; Chan P
J Surg Oncol; 1978; 10(1):73-7. PubMed ID: 628221
[TBL] [Abstract][Full Text] [Related]
24. A study of T-lymphocytes and delayed cutaneous hypersensitivity reaction in patients with squamous cell carcinoma of head and neck region.
Singh SN; Agrawal BM; Shanker R; Rajvanshi VS
Indian J Cancer; 1979; 16(3-4):53-8. PubMed ID: 317272
[No Abstract] [Full Text] [Related]
25. Delayed cutaneous hypersensitivity ad peripheral blood lymphocyte counts in gastrointestinal cancer.
Gupta S; Seth SK; Udupa KN; Sen PC
Ann Acad Med Singap; 1980 Jan; 9(1):71-6. PubMed ID: 7447383
[TBL] [Abstract][Full Text] [Related]
26. Correlation of preoperative immunologic test results with recurrence in patients with head and neck cancer.
Ryan RE; Neel HB; Ritts RE
Otolaryngol Head Neck Surg (1979); 1980; 88(1):58-63. PubMed ID: 6967203
[TBL] [Abstract][Full Text] [Related]
27. Clinical studies on cell-mediated immunity in gestational trophoblastic disease: nonspecific cellular immunocompetence in patients with hydatid mole and trophoblastic neoplasia.
Sasaki T; Fujisaki S
Microbiol Immunol; 1981; 25(4):387-401. PubMed ID: 6265741
[TBL] [Abstract][Full Text] [Related]
28. A prospective study of immune responsiveness in human melanoma. I. Assessment of initial pretreatment status with stage of disease.
Pritchard DJ; Ritts RE; Taylor WF; Miller GC
Cancer; 1978 Jun; 41(6):2165-73. PubMed ID: 306870
[TBL] [Abstract][Full Text] [Related]
29. ["Active" rosettes and skin tests to recall antigens and phytohemagglutinin in 48 patients with non metastatic squamous cell lung carcinoma and before treatment (author's transl)].
Lang JM; Pauli G; Roeslin N; Bigel P; Bessot JC
Rev Fr Mal Respir; 1980; 8(1):11-6. PubMed ID: 6970392
[TBL] [Abstract][Full Text] [Related]
30. Unique immunobiological aspects of head and neck squamous carcinoma.
Chretien PB
Can J Otolaryngol; 1975; 4(2):225-35. PubMed ID: 166742
[TBL] [Abstract][Full Text] [Related]
31. A correlative analysis of in vitro parameters of cellular immunity in patients with squamous cell carcinoma of the head and neck.
Deegan MJ; Coulthard SW; Quaiman SJ; Schork MA
Cancer Res; 1977 Dec; 37(12):4475-81. PubMed ID: 144562
[No Abstract] [Full Text] [Related]
32. Immune monitoring protocol for patients with carcinoma of the head and neck. Preliminary report.
Veltri RW; Sprinkle PM; Maxim PE; Theofilopoulos AN; Rodman SM; Kinney CL
Ann Otol Rhinol Laryngol; 1978; 87(5 Pt 1):692-700. PubMed ID: 309748
[TBL] [Abstract][Full Text] [Related]
33. In vivo and in vitro assays of immunocompetence in bronchogenic carcinoma.
Alsabti EA
Oncology; 1979; 36(4):171-5. PubMed ID: 157453
[TBL] [Abstract][Full Text] [Related]
34. Peripheral blood T and B lymphocytes, in vitro stimulation with phytohemagglutinin, and sensitization with 2,4-dinitrochlorobenzene in Grave's disease.
Maciel RM; Miki SS; Nicolau W; Mendes NF
J Clin Endocrinol Metab; 1976 Mar; 42(3):583-7. PubMed ID: 767355
[TBL] [Abstract][Full Text] [Related]
35. Immunologic evaluation of patients with advanced head and neck cancer receiving weekly chemoimmunotherapy.
Zighelboim J; Dorey F; Parker NH; Calcaterra T; Ward P; Fahey JL
Cancer; 1979 Jul; 44(1):117-23. PubMed ID: 313240
[TBL] [Abstract][Full Text] [Related]
36. Critical evaluation of lymphocyte functions in urological cancer patients.
Elhilali MM; Paika KD; Brosman S; Fahey JL
Cancer Res; 1976 Jan; 36(1):132-7. PubMed ID: 1082369
[TBL] [Abstract][Full Text] [Related]
37. Delayed cutaneous hypersensitivity and peripheral lymphocyte counts in patients with advanced cancer.
Lee YT; Sparks FC; Eilber FR; Morton DL
Cancer; 1975 Mar; 35(3):748-55. PubMed ID: 1111942
[TBL] [Abstract][Full Text] [Related]
38. Cell-mediated immunity in the rheumatoid diseases. I. Skin testing and mitogenic responses in sero-negative arthritides.
Froebel K; Sturrock RD; Dick WC; MacSween RN
Clin Exp Immunol; 1975 Dec; 22(3):446-52. PubMed ID: 1083785
[TBL] [Abstract][Full Text] [Related]
39. [Immunological monitoring of patients with carcinoma of the lung. Study method and preliminary research].
Banna P; Stivala F; Murabito R; Cordopatri F; Saggio A; Mosca F; Cinà C
Chir Ital; 1979 Dec; 31(6):1297-1313. PubMed ID: 233422
[TBL] [Abstract][Full Text] [Related]
40. Peripheral K-lymphocyte population in head and neck cancer.
Hayashi Y; Nishida T; Yoshida H; Yanagawa T; Yura Y; Nitta T; Sato M
Cancer; 1984 Jun; 53(11):2507-14. PubMed ID: 6608986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
